| abnormalities of membranes | P02.9 | Newborn affected by abnormality of membranes, unspecified | |
| abruptio placenta | P02.1 | Newborn affected by other forms of placental separation and hemorrhage | |
| amino-acid metabolic disorder, transitory | P74.8 | Other transitory metabolic disturbances of newborn | |
| amniocentesis | P00.6 | Newborn affected by surgical procedure on mother | |
| amnionitis | P02.78 | Newborn affected by other conditions from chorioamnionitis | |
| apparent life threatening event | R68.13 | Apparent life threatening event in infant (ALTE) | |
| breech delivery | P03.0 | Newborn affected by breech delivery and extraction | |
| cardiac arrest | P29.81 | Cardiac arrest of newborn | |
| cardiomyopathy | I42.89 | Other cardiomyopathies not elsewhere classified | |
| cerebral ischemia | P91.0 | Neonatal cerebral ischemia | |
| Cesarean delivery | P03.4 | Newborn affected by Cesarean delivery | |
| chemotherapy agents | P04.11 | Newborn affected by maternal antineoplastic chemotherapy | |
| chorioamnionitis | P02.78 | Newborn affected by other conditions from chorioamnionitis | |
| cocaine | P04.41 | Newborn affected by maternal use of cocaine | |
| complications of labor and delivery | P03.9 | Newborn affected by complication of labor and delivery, unspecified | |
| compression of umbilical cord NEC | P02.5 | Newborn affected by other compression of umbilical cord | |
| contracted pelvis | P03.1 | Newborn affected by other malpresentation, malposition and disproportion during labor and delivery | |
| cyanosis | P28.2 | Cyanotic attacks of newborn | |
| delivery | P03.9 | Newborn affected by complication of labor and delivery, unspecified | |
| drugs of addiction | P04.40 | Newborn affected by maternal use of unspecified drugs of addiction | |
| environmental chemicals | P04.6 | Newborn affected by maternal exposure to environmental chemical substances | |
| entanglementin umbilical cord | P02.5 | Newborn affected by other compression of umbilical cord | |
| FIRS | P02.70 | Newborn affected by fetal inflammatory response syndrome | |
| forceps delivery | P03.2 | Newborn affected by forceps delivery | |
| hemorrhage | P02.1 | Newborn affected by other forms of placental separation and hemorrhage | |
| hypoxic ischemic encephalopathy [HIE] | P91.60 | Hypoxic ischemic encephalopathy [HIE], unspecified | |
| induction of labor | P03.89 | Newborn affected by other specified complications of labor and delivery | |
| intestinal perforation | P78.0 | Perinatal intestinal perforation | |
| intrauterineblood loss | P50.9 | Newborn affected by intrauterine (fetal) blood loss, unspecified | |
| intrauterinehemorrhage | P50.9 | Newborn affected by intrauterine (fetal) blood loss, unspecified | |
| intrauterineprocedure | P96.5 | Complication to newborn due to (fetal) intrauterine procedure | |
| malpresentationNEC | P03.1 | Newborn affected by other malpresentation, malposition and disproportion during labor and delivery | |
| meconium peritonitis | P78.0 | Perinatal intestinal perforation | |
| medication | P04.19 | Newborn affected by maternal use of unspecified medication | |
| membrane abnormalities | P02.9 | Newborn affected by abnormality of membranes, unspecified | |
| membranitis | P02.78 | Newborn affected by other conditions from chorioamnionitis | |
| methamphetamine | P04.49 | Newborn affected by maternal use of other drugs of addiction | |
| mixed metabolic and respiratory acidosis | P84 | Other problems with newborn | |
| neonatal abstinence syndrome | P96.1 | Neonatal withdrawal symptoms from maternal use of drugs of addiction | |
| noxious substances transmitted via placenta or breast milk | P04.9 | Newborn affected by maternal noxious substance, unspecified | |
| nutritional supplements | P04.5 | Newborn affected by maternal use of nutritional chemical substances | |
| placenta previa | P02.0 | Newborn affected by placenta previa | |
| placentitis | P02.78 | Newborn affected by other conditions from chorioamnionitis | |
| precipitate delivery | P03.5 | Newborn affected by precipitate delivery | |
| prolapsed cord | P02.4 | Newborn affected by prolapsed cord | |
| respiratory arrest | P28.81 | Respiratory arrest of newborn | |
| slow intrauterine growth | P05.9 | Newborn affected by slow intrauterine growth, unspecified | |
| tobacco | P04.2 | Newborn affected by maternal use of tobacco | |
| twin to twin transplacental transfusion | P02.3 | Newborn affected by placental transfusion syndromes | |
| umbilical cordaround neck | P02.5 | Newborn affected by other compression of umbilical cord | |
| umbilical cord condition | P02.60 | Newborn affected by unspecified conditions of umbilical cord | |
| uterine contractions | P03.6 | Newborn affected by abnormal uterine contractions | |
| vasa previa | P02.69 | Newborn affected by other conditions of umbilical cord | |
| abnormalities of membranes › specified NEC | P02.8 | Newborn affected by other abnormalities of membranes | |
| bleeding › cerebral cortex | P52.22 | Intraventricular (nontraumatic) hemorrhage, grade 4, of newborn | |
| bleeding › germinal matrix | P52.0 | Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn | |
| bleeding › ventricles | P52.1 | Intraventricular (nontraumatic) hemorrhage, grade 2, of newborn | |
| cardiomyopathy › congenital | I42.4 | Endocardial fibroelastosis | |
| complications of labor and delivery › specified NEC | P03.89 | Newborn affected by other specified complications of labor and delivery | |
| delivery › Cesarean | P03.4 | Newborn affected by Cesarean delivery | |
| delivery › forceps | P03.2 | Newborn affected by forceps delivery | |
| delivery › vacuum extractor | P03.3 | Newborn affected by delivery by vacuum extractor [ventouse] | |